Company Performance Metrics
CarMa Global Enterprise operates as the strategic advisory, investor relations, and capital strategy arm of CarMa Global Enterprise. It advises life science, biotechnology, digital health, and frontier deep-tech companies on navigating fundraising from early stages through Series C. The firm focuses on connecting scientifically driven founders with
capital pools such as family offices and other patient investors, particularly across MENA and APAC. Its work includes designing capital strategies, guiding investor outreach, and aligning funding plans with long-term clinical and technological objectives. CarMa Global Enterprise emphasizes rigorous understanding of underlying science to shape clear, narrative-driven investor materials. It supports companies working on areas such as neurodegenerative disease, oncology, cell therapy platforms, and medical artificial intelligence architectures.